Simplex Trading
GEVA

Simplex Trading’s SYNAGEVA BIOPHARMA CORP COM STK (DE) GEVA Stock Holding History

Simplex Trading’s Portfolio GEVA Stock Details GEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-42
Closed -$27K – 6463
2015
Q1 		$27K Buy
+42
New +$4.45K ﹤0.01% 2097

Simplex Trading's GEVA Position: Q1 2015 in Review

Simplex Trading sold out of SYNAGEVA BIOPHARMA CORP COM STK (DE) (GEVA) in Q1 2015, closing a stake of 6,989 shares — an estimated $740K sold.

Simplex Trading first reported a position in GEVA in Q4 2014 and held it in 1 quarter. The position peaked at $649K in Q4 2014. 130 funds tracked by Wall St. Rank hold GEVA as of Q1 2015.

  • Simplex Trading reported no remaining SYNAGEVA BIOPHARMA CORP COM STK (DE) position as of Q1 2015 after selling out during the quarter.
  • Simplex Trading sold 6,989 SYNAGEVA BIOPHARMA CORP COM STK (DE) shares in Q1 2015, an estimated $740K.
  • Simplex Trading first reported a position in SYNAGEVA BIOPHARMA CORP COM STK (DE) in Q4 2014 and held it in 1 quarter.
  • Simplex Trading's SYNAGEVA BIOPHARMA CORP COM STK (DE) position peaked at $649K in Q4 2014.
  • 130 funds tracked by Wall St. Rank held SYNAGEVA BIOPHARMA CORP COM STK (DE) as of Q1 2015.

Based on Simplex Trading's 13F filing for Q1 2015, filed 21 Apr 2015.